Ovarian Cancer
2018 Ovarian Cancer Research Highlights
- BRCA in Ovarian Cancer: Understanding the Risk and Finding New Means of Treatment
- A Multi-Institutional Approach to Understanding the Pathology of Ovarian Cancer
- A More Reliable Personalized Medicine-Based Approach to Test Ovarian Cancer Drugs
- Cyclin E1 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
- The Impact of the Ovarian Cancer Academy Is Long-Lasting and Far-Reaching
- Investigation of a Novel PET Tracer to Assess PARP Inhibitor Sensitivity in Ovarian Cancer Patients
Last updated Thursday, May 26, 2022